XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.

Alibaba reports earnings amid China’s new wave of lockdowns – Stock Market News



Alibaba is set to announce its fourth quarter financial results for the 2022 fiscal year on Thursday. The company’s shares have been plunging since early 2021 as the online retail behemoth was caught in the middle of a major regulatory crackdown on multiple sectors of the Chinese economy. To make matters worse, the upcoming earnings report is expected to indicate a deterioration in the firm’s financials due to the renewed round of Covid-19 restrictions in China that appear to have severely impacted its e-commerce business. Nevertheless, the consensus recommendation from Refinitiv analysts is ‘buy’, suggesting solid growth prospects for the firm.

Alibaba underperforms amid lingering regulatory and macro hurdles

China’s retail giants have seen their earnings estimates for Q1 getting slashed amid the government’s pursuit of zero-Covid strategy, which has slowed down manufacturing production and deteriorated supply chain disruptions. In turn, these developments have been constantly increasing fears over a slowdown in growth alongside discouraging consumer spending.

This latest development is added to a raft of existing challenges that most major Chinese companies have been grappling with, including a long-lasting regulatory assault by the government and the global monetary tightening, which has been luring capital away from risky assets. Meanwhile, the effect of the Chinese government’s latest stimulus package has proved non-existent as April’s retail sales slumped 2.5% month-on-month, marking an annual decrease of 6%.

The ongoing war is also exacerbating major Chinese enterprises’ outlook. China remains an ally of Russia, which could have potentially tempered US investors’ demand for Alibaba's stock, even if it retains substantial growth prospects. The war in Ukraine has also heightened the significance of geopolitical factors for investors, with some becoming wary of the economic and financial consequences of possible increased tension between China and the West in the future. Furthermore, the American regulators have recently added JD.com to the provisional list of companies that may be removed from the American exchange if they fail to adhere to the rules regarding foreign companies' operating framework. Therefore, the fear of a potential delisting could also be partly responsible for Alibaba’s recent underperformance.

Idiosyncratic risks on the table

Alibaba has been adversely impacted by the cloudy Chinese macro environment and the long-lasting regulatory woes, which have enabled its competitors to gain part of its market share. Additionally, the recent lockdown has applied upward pressure to its operational costs, making the firm unable to keep its prices as low as its major US rivals. In turn, lower profit margins lead to decreasing net earnings that incentivise investors to steer towards more profitable companies.

Aside from that, in April, Warren Buffett's partner Charlie Munger cut his Alibaba stake by 50%, after building up the position for over a year. Following that news, Alibaba's share price experienced a sharp decline, with investors attributing this move to company-specific jitters.

Share buybacks the only bright spot

In March, Alibaba revealed that it plans to boost its share repurchase program from $10 to $25 billion in an effort to support its collapsing share price, which was mainly attributed to external repercussions.

In contrast to most American firms that have been buying back their stocks at significantly elevated prices, Alibaba has been trading at relatively cheap valuations as a result of the continuous sell-off. Hence, the recently announced buyback program could prove beneficial for long-term investors that plan to enter in these low-price levels.

Tough quarter

Mixed financial figures are expected for Alibaba as the zero-Covid policy imposed in China appears to have largely weighed on consumer spending. The retail behemoth is expected to post revenue of $199 billion for the fourth quarter, according to consensus estimates by Refinitiv IBES, which would represent a year-on-year growth of 6% but an 18% drop from the last quarter. Additionally, earnings per share (EPS) are estimated to decrease from $16.87 in the previous quarter to $7.29, marking a 29% decline on an annual basis.

Valuation has become attractive

Although Alibaba realized huge gains after the Covid-19 pandemic outbreak, this lockdown appears to have an adverse impact on the firm as it is also facing tough challenges because of the current uncertain macroeconomic outlook of the Chinese economy. The firm is currently undervalued with a trailing 12-month price to earnings (P/E) ratio of 11.1 (as of May 11, 2022), which is lower than its sector’s average of 27.7. Moreover, its forward 12-month P/E ratio is currently at 10.6, with most of its major competitors reporting a higher figure.

Overall, these indications could also suggest that due to the persistent sell-off, Alibaba’s share price has reached ‘value’ territory. Therefore, the firm’s attractive valuation alongside its significant growth prospects could skew long-term investors’ risk-reward ratio to the upside, given that Alibaba would manage to overcome its short-term headwinds.

Alibaba’s stock in freefall

Taking a technical look at Alibaba, a negative long-term outlook can be observed as the share price has been losing ground since the beginning of 2021. Even though the firm has been posting solid earnings figures in recent quarters, its stock price has failed to halt the decline, indicating that investors are more concerned about the broader macro risks of the Chinese economy.

Nevertheless, in case of stronger-than-expected financial results, the stock price could test its recent resistance barrier of $102. Should buying interest intensify further, then the next obstacle could be met at $124.

On the other hand, if earnings disappoint, initial support may be found near the recent low of $81.5, where a potential violation would turn the focus towards the 2022 low of $73.

면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.

온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.

이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.

리스크 경고: 고객님의 자본이 위험에 노출 될 수 있습니다. 레버리지 상품은 모든 분들에게 적합하지 않을수 있습니다. 당사의 리스크 공시를 참고하시기 바랍니다.